
Not meant to depict the results of actual
treatment with DUPIXENT.
The mechanism of dupilumab action has not been
definitively established.
- DUPIXENT is not an immunosuppressant1
- DUPIXENT requires no initial lab testing or ongoing lab monitoring, according to the Prescribing Information1
- DUPIXENT is not metabolized through the liver or excreted through the kidneys1
- No known drug-to-drug interactions
Identifying DUPIXENT Patients
Consider whether your patient with uncontrolled prurigo nodularis may
be a candidate for DUPIXENT. Take a look at our patient profiles.
be a candidate for DUPIXENT. Take a look at our patient profiles.